dr. wakelee on fda approval of frontline pembrolizumab in nsclc
Published 7 years ago • 127 plays • Length 1:54Download video MP4
Download video MP3
Similar videos
-
1:29
dr. wakelee on available treatments following tumor progression in lung cancer
-
1:15
dr. spigel on fda approval of pembrolizumab/chemo combo in nsclc
-
2:15
dr. wakelee on birch trial for atezolizumab in patients with nsclc
-
0:55
dr. west on fda approval of frontline alectinib in alk nsclc
-
0:36
dr. camidge on the fda approval of pembrolizumab for squamous nsclc
-
0:35
dr. farago on the fda approval of pembrolizumab for lower pd-1 cutoff nsclc
-
3:14
dr. west on fda approval of frontline osimertinib in egfr nsclc
-
2:30
dr. lopes on the keynote-042 results of frontline pembrolizumab in nsclc
-
0:40
copy of dr. west on fda approval of frontline osimertinib in egfr nsclc
-
3:02
dr. ou on the fda approval of pembrolizumab in sclc
-
1:32
dr. wakelee on immunotherapy versus targeted agents in nsclc
-
1:46
dr. wakelee on single-agent immunotherapy in nsclc
-
1:21
fda approval of frontline osimertinib in frontline egfr-mutant nsclc
-
1:33
dr. wakelee on continued maintenance in lung cancer
-
1:27
dr. grothey on fda approval of pembrolizumab in msi-high crc
-
5:31
fda approval: frontline ceritinib for alk nsclc
-
1:16
dr. wakelee on first-line therapy for egfr-mutant lung cancer
-
1:08
dr. horn on the fda approval of atezolizumab plus bevacizumab and chemotherapy in nsclc
-
1:55
dr. heather wakelee discusses nintedanib plus chemotherapy in nsclc